Michael Amoroso
Chief Executive Officer bei PRECISION BIOSCIENCES, INC.
Vermögen: 735 212 $ am 31.03.2024
Profil
Michael Amoroso is currently the President, Chief Executive Officer & Director at Precision BioSciences, Inc. He is also the Chairman at Abeona Therapeutics, Inc. Previously, he worked as the SVP & Head-Cell Therapy Worldwide Commercial at Kite Pharma, Inc. Michael completed his undergraduate degree at Rider University and holds an MBA from The Leonard N Stern School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.03.2024 | 79 187 ( 0,29% ) | 574 106 $ | 31.03.2024 | |
| 18.04.2024 | 11 881 ( 0,18% ) | 161 106 $ | 31.03.2024 |
Aktive Positionen von Michael Amoroso
| Unternehmen | Position | Beginn |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Chairman | 14.10.2021 |
| PRECISION BIOSCIENCES, INC. | Chief Executive Officer | 15.10.2021 |
Ehemalige bekannte Positionen von Michael Amoroso
| Unternehmen | Position | Ende |
|---|---|---|
| KITE PHARMA INC | Corporate Officer/Principal | 01.01.2020 |
Ausbildung von Michael Amoroso
| Rider University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ABEONA THERAPEUTICS INC. | Health Technology |
| PRECISION BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
